Baby NINJA项目:减少新生儿重症监护病房中肾毒性药物相关急性肾损伤
该质量改进项目在单中心IV级新生儿重症监护病房开展,通过系统监测高风险肾毒性药物暴露并每日检测血清肌酐,比较实施前后指标变化。结果显示高肾毒性药物暴露率、肾毒性药物相关急性肾损伤百分比及急性肾损伤强度均显著下降,在持续18个月期间预防了100例急性肾损伤发作。
要点
- 系统监测高风险肾毒性药物暴露并每日检测血清肌酐可减少新生儿重症监护病房的急性肾损伤。
核心结论
- 系统监测项目可识别高风险婴儿并预防肾毒性药物诱导的急性肾损伤。
- 该项目有潜力预防危重婴儿急性肾损伤的短期和长期后果。
研究设计与样本
- 单中心IV级新生儿重症监护病房于2015年3月至2017年9月开展的质量改进项目。
- 婴儿筛查高风险肾毒性药物暴露标准为24小时内≥3种肾毒性药物或静脉氨基糖苷类用药≥4个日历日。
- 符合标准者每日检测血清肌酐直至暴露结束后2天或急性肾损伤结束后2天(以较晚者为准)。
- 研究分为3个时期:NINJA实施前、启动期和持续期,比较5项指标差异。
主要发现
- 在18个月持续期内预防了100例急性肾损伤发作。
关键数值与推荐
- 高风险肾毒性药物暴露定义为24小时内≥3种肾毒性药物或静脉氨基糖苷类用药≥4个日历日。
- 符合标准者每日检测血清肌酐直至暴露结束后2天或急性肾损伤结束后2天(以较晚者为准)。
临床怎么用
- 对新生儿重症监护病房婴儿系统筛查高风险肾毒性药物暴露。
- 对符合标准者每日监测血清肌酐直至暴露或急性肾损伤结束后2天。
- 通过及时识别和干预减少肾毒性药物相关急性肾损伤。
局限性
- 单中心质量改进项目,结果外推需谨慎。
- 研究设计非随机对照,无法排除其他因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE(S): To test if acute kidney injury (AKI) is preventable in patients in the neonatal intensive care unit and if infants at high-risk of nephrotoxic medication-induced AKI can be identified using a systematic surveillance program previously used in the pediatric non-intensive care unit setting. STUDY DESIGN: Quality improvement project that occurred between March 2015 and September 2017 in a single center, level IV neonatal intensive care unit. Infants were screened for high-risk nephrotoxic medication exposure (≥3 nephrotoxic medication within 24 hours or ≥4 calendar days of an intravenous [IV] aminoglycoside). If infants met criteria, a daily serum creatinine (SCr) was obtained until 2 days after end of exposure or end of AKI, whichever occurred last. The study was divided into 3 eras: pre-Nephrotoxic Injury Negated by Just-in-time Action (NINJA), initiation, and sustainability. Differences for 5 metrics across 3 eras were compared: SCr surveillance, high nephrotoxic medication exposure rate (per 1000 patient-days), AKI rate (per 1000 patient-days), nephrotoxin-AKI percentage, and AKI intensity (number of AKI days per 100 susceptible patient-days). RESULTS: Comparing the initiation with sustainability era, there was a reduction in high nephrotoxic medication exposures from 16.4 to 9.6 per 1000 patient-days (P = .03), reduction in percentage of nephrotoxic medication-AKI from 30.9% to 11.0% (P < .001), and reduction in AKI intensity from 9.1 to 2.9 per 100 susceptible patient-days (P < .001) while maintaining a high SCr surveillance rate. This prevented 100 AKI episodes during the 18-month sustainability era. CONCLUSION(S): A systematic surveillance program to identify high-risk infants can prevent nephrotoxic-induced AKI and has the potential to prevent short and long-term consequences of AKI in critically ill infants.
引用
- Stoops C, Stone S, Evans E, et al. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in the Neonatal Intensive Care Unit. J Pediatr. 2019. PMID: 31761141. doi:10.1016/j.jpeds.2019.08.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。